OUR SERVICESAntibiotic Resistance (ABR) gene panel

Antibiotic Resistance (ABR) gene panel

At least 2 million people get an antibiotic-resistant infection each year in the United States and at least 23,000 people die, according to the Centers for Disease Control and Prevention (CDC). It can often take several days to get results under the current standard of care for diagnosing bloodstream infections caused by antimicrobial-resistant pathogens, so antibiotics may be prescribed before it is known whether the strain is resistant to that treatment. The Antibiotics Resistance (ABR) panel developed by AIM Labs, is designed to expedite the right diagnosis, so patients can get targeted treatment sooner. A faster diagnosis also can cut down on the unnecessary use of antimicrobial drugs.

Contact Us Today

    Contact Us Today


      Screenings for Drugs of Abuse

      • Employment screening
      • Clinical Testing

      Prescription Compliance Testing

      • Patient compliance to prescribing instructions
      • Patient drug metabolism

      Testing specifications (need to find a better title)

      • Urine drug screening
      • Positive and negative results
      • Confirmation testing with quantifiable results
      • Identification of non-prescribed medications for patients that test positive